✦ LIBER ✦

National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: Evaluation of Exemestane to Prevent Breast Cancer in Postmenopausal Women

✍ Scribed by Paul E. Goss; Harriet Richardson; Rowan Chlebowski; Dianne Johnston; Gloria E. Sarto; Elizabeth Maunsell; James N. Ingle; José E. Alés-Martinez

Book ID: 115075763
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 94 KB
Volume: 7
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2007.n.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical cooperative trials of the natio

Clinical cooperative trials of the national cancer institute of Canada clinical trials group breast cancer site group

✍ Kathleen I. Pritchard 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Evaluating Health-Related Quality of Lif

Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience

✍ David Osoba; Andrea Bezjak; Michael Brundage; Joseph Pater 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Quality of Life in MAP.3 (Mammary Preven

Quality of Life in MAP.3 (Mammary Prevention 3): A Randomized, Placebo-Controlled Trial Evaluating Exemestane for Prevention of Breast Cancer

✍ Maunsell, E.; Goss, P. E.; Chlebowski, R. T.; Ingle, J. N.; Ales-Martinez, J. E. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 249 KB

Prospective Cost-Effectiveness Analysis

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

✍ Mittmann, N.; Au, H.-J.; Tu, D.; O'Callaghan, C. J.; Isogai, P. K.; Karapetis, C 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 486 KB

Phase II study of flutamide in patients

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study

✍ Daniele J. Perrault; Diane M. Logan; David J. Stewart; Vivien H. C. Bramwell; Al 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 271 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of the oral antiandrogen flutamide in 33 patients with metastatic breast cancer. Eight patients had received no prior systemic therapy for their metastatic disease and 13 had only one site of metastasis.

A randomized crossover trial of tamoxife

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

✍ Carol A. Sawka; Kathleen I. Pritchard; Wendy Shelley; Gerrit DeBoer; Alexander H 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 32 KB